8-K ·Filed Jul 6, 2026

OMER

OMEROS CORP
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago SEC0001552781-26-000377
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The note repurchases reduce potential dilution from conversion, a modest positive for equity holders. Watch for announcement of replacement debt financing, which could alter leverage. The second tranche closes by July 30 — monitor for any adjustments based on stock price during the averaging period.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
OMER ▲ +86.17% at T+60d
NEUTRAL call ✓ call won +86.17% · α vs SPY +84.45% · entry $10.34 → $19.25
Entry anchored
Jul 2, 03:59 PM ET
via exchange tick
T+1d
-0.10%
call -0.10% · α +0.38%
$10.33
settled 3mo ago
T+5d
-0.58%
call -0.58% · α -1.07%
$10.28
settled 3mo ago
T+20d
+14.51%
call +14.51% · α +15.07%
$11.84
settled 2mo ago
T+60d
+86.17%
call +86.17% · α +84.45%
$19.25
settled 3d ago

Price Chart

Loading chart...

Executive Summary

Omeros disclosed the completion of a $16.0M principal repurchase of its 9.50% Convertible Senior Notes due 2029 for ~$31.3M, and entered new agreements to repurchase up to an additional $14.5M principal for up to ~$31.0M. These transactions reduce convertible debt overhang and potential dilution, but consume significant cash that may be replaced with non-convertible debt.

Key Facts

  • Completed repurchase of $16.0M aggregate principal amount of 9.50% Convertible Senior Notes due 2029 for ~$31.3M total, leaving $54.8M outstanding.
  • Entered new agreements to repurchase up to ~$14.5M additional principal for up to ~$31.0M, expected to close July 20–30, 2026.
  • If fully executed, ~$40.3M aggregate principal of Notes will remain outstanding.
  • Company may replace cash used with unsecured or limited-collateral debt not convertible into equity.

Financial Impact

Total cash outlay of up to ~$62.3M for both tranches, representing ~9.3% of market cap ($672M). Reduces convertible debt from ~$71.3M to ~$40.3M.

debtdilutioncash

Risk Factors

  • Cash depletion of ~$62.3M may pressure liquidity if not replaced with new debt.
  • New non-convertible debt could increase leverage and interest expense.
  • Repurchase premium (~2x principal) reflects significant cost to retire the notes.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001552781-26-000377
Document: 0001552781-26-000377-index-headers.html0001552781-26-000377
Document: 0001552781-26-000377-index.html0001552781-26-000377
Document: 0001552781-26-000377.txt0001552781-26-000377
10 reports for OMER
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +80.38%Jul 20, 2026
Filters
Rows
Reports for OMER — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.75 $19.04▲ +1.55%▲ +1.44%$18.33 (−2.21%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 5/10
$18.61 $19.43▲ +4.41%▲ +4.15%$18.33 (−1.48%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.22 $20.13▲ +10.48%▲ +10.26%$18.33 (+0.63%)
Aug 21, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$19.32 $21.05▲ +8.95%▲ +7.64%$18.33 (−5.10%)
Jul 20, 2026
10w ago
8-K
BULLISH ★ 5/10
$9.53 $17.19▲ +80.38%▲ +77.82%$18.33 (+92.39%)
Jul 6, 2026
12w ago
8-K
NEUTRAL ★ 4/10
$10.34 $11.84▲ +14.51%▲ +15.07%$18.33 (+77.32%)
Jun 18, 2026
15w ago
8-K
BULLISH ★ 5/10
$10.28 $9.22▼ −10.31%▼ −10.84%$18.33 (+78.36%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 4/10
$10.18 $10.27▲ +0.88%▼ −1.01%$18.33 (+80.11%)
May 13, 2026
20w ago
8-K
MIXED ★ 6/10
$13.28 $8.74▼ −34.19%▼ −33.33%$18.33 (+38.06%)
Mar 31, 2026
26w ago
8-K
BULLISH ★ 9/10
$12.08 $14.56▲ +20.53%▲ +10.81%$18.33 (+51.78%)
Showing 10 of 10

US Market Status

Market Open — Closes in 3h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access